251 related articles for article (PubMed ID: 25760365)
21. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.
Ronco P; Debiec H
Mol Immunol; 2015 Nov; 68(1):57-62. PubMed ID: 26597209
[TBL] [Abstract][Full Text] [Related]
22. Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy.
Debiec H; Ronco P
Nat Rev Nephrol; 2011 Aug; 7(9):496-8. PubMed ID: 21826078
[No Abstract] [Full Text] [Related]
23. Genetic determinants of the development and course of membranous nephropathy.
Kamyshova ES; Bobkova IN; Gorelova IA; Каkhsurueva PA; Filatova EE
Ter Arkh; 2018 Jun; 90(6):105-111. PubMed ID: 30701913
[TBL] [Abstract][Full Text] [Related]
24. Membranous nephropathy-one morphologic pattern with different diseases.
Hoxha E; von Haxthausen F; Wiech T; Stahl RAK
Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350
[TBL] [Abstract][Full Text] [Related]
25. Unmet challenges in membranous nephropathy.
Salant DJ
Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):70-76. PubMed ID: 30451735
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathogenesis of Membranous Nephropathy.
Ronco P; Debiec H
Annu Rev Pathol; 2020 Jan; 15():287-313. PubMed ID: 31622560
[TBL] [Abstract][Full Text] [Related]
27. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.
Stahl R; Hoxha E; Fechner K
N Engl J Med; 2010 Jul; 363(5):496-8. PubMed ID: 20818871
[No Abstract] [Full Text] [Related]
28. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.
Debiec H; Ronco P
N Engl J Med; 2011 Feb; 364(7):689-90. PubMed ID: 21323563
[No Abstract] [Full Text] [Related]
29. Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
Hofstra JM; Wetzels JF
Neth J Med; 2012 Apr; 70(3):109-13. PubMed ID: 22516574
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion: A retrospective observational study.
Cheng W; Sun L; Dong H; Wang G; Ye N; Wang Y; Cheng H
Medicine (Baltimore); 2021 Jan; 100(3):e23988. PubMed ID: 33545990
[TBL] [Abstract][Full Text] [Related]
31. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
Matsumoto A; Matsui I; Mano K; Mizuno H; Katsuma Y; Yasuda S; Shimada K; Inoue K; Oki T; Hanai T; Kojima K; Kaneko T; Isaka Y
BMC Nephrol; 2021 Jul; 22(1):253. PubMed ID: 34229600
[TBL] [Abstract][Full Text] [Related]
32. Factor H Autoantibodies and Membranous Nephropathy.
Seikrit C; Ronco P; Debiec H
N Engl J Med; 2018 Dec; 379(25):2479-2481. PubMed ID: 30575481
[No Abstract] [Full Text] [Related]
33. Is primary membranous nephropathy a complement mediated disease?
Reinhard L; Stahl RAK; Hoxha E
Mol Immunol; 2020 Dec; 128():195-204. PubMed ID: 33142137
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosis.
Morel A; Buob D; Goujon JM; Belhadj K; Verpont MC; Audard V; Moktefi A
Pathology; 2022 Aug; 54(5):654-657. PubMed ID: 34774302
[No Abstract] [Full Text] [Related]
35. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
[TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
37. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.
Hofstra JM; Wetzels JF
J Am Soc Nephrol; 2014 Jun; 25(6):1137-9. PubMed ID: 24610931
[No Abstract] [Full Text] [Related]
39. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
40. Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
Beck LH
Am J Kidney Dis; 2024 May; 83(5):566-568. PubMed ID: 38260930
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
